Insiders who reported open-market trades in the last 12 months at the companies Mir A. Imran files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Mir A. Imran is a corporate insider of Rani Therapeutics Holdings, Inc. (RANI). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Mir A. Imran submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Mir A. Imran been buying or selling stock?
Recorded transactions: 3 open-market purchases ($1.29M) and 0 open-market sales across all tracked filings.
Mir A. Imran files SEC Form 4 reports at Rani Therapeutics Holdings, Inc. (RANI). 5 SEC Form 4 filings on record going back to 2024, most recently on 23 July 2026. Most recent open-market trade: bought $25K of RANI on 23 July 2026. Lifetime open-market purchases: $1.29M.
Recent transactions
2
The latest 2 SEC Form 4 transactions reported by Mir A. Imran.
InsiderAlpha's records for Mir A. Imran go back to 2024: 5 primary Form 4 filings, an average of 1.7 per year. The typical open-market purchase is $643K (2 of 3 buys carry a usable dollar value, totaling $1.29M). The largest single buy on record is $1.26M of RANI in 2025. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
